Paclitaxel 300mg/50ml solution for infusion vials
NHS hospitals in England used £28,988,739 of indicative cost of Paclitaxel 300mg/50ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 69.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Paclitaxel 300mg/50ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Paclitaxel 300mg/50ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University College London Foundation Tr | £2,523,763 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,678,537 |
| St George's Univ Hosps Foundation Nhst | £1,448,852 |
| South Tees Hosp Nhs Foundation Trust | £1,242,407 |
| The Christie Nhs Foundation Trust | £1,200,473 |
| United Lincolnshire Hospitals Nhs Trust | £1,019,854 |
| Sheffield Teaching Hospitals Nhs Trust | £844,100 |
| Southend Univ Hosp Nhs Foundation Trust | £764,758 |
| Royal Surrey County Hosp Nhs Found Trust | £740,185 |
| Nottingham University Hospitals Trust | £725,488 |
The primary-care picture
Paclitaxel is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Paclitaxel medicine page.